| Primary |
| Depression |
36.4% |
| Drug Use For Unknown Indication |
27.8% |
| Anxiety |
10.2% |
| Product Used For Unknown Indication |
6.5% |
| Insomnia |
4.0% |
| Panic Disorder |
2.6% |
| Hypertension |
1.4% |
| Obsessive-compulsive Disorder |
1.2% |
| Panic Attack |
1.2% |
| Constipation |
1.1% |
| Bipolar Disorder |
1.1% |
| Anxiety Disorder |
1.0% |
| Pregnancy |
1.0% |
| Major Depression |
0.8% |
| Pain |
0.7% |
| Migraine |
0.7% |
| Nausea |
0.6% |
| Social Phobia |
0.6% |
| Postpartum Depression |
0.6% |
| Asthma |
0.5% |
|
| Drug Exposure During Pregnancy |
27.0% |
| Ventricular Septal Defect |
17.1% |
| Drug Ineffective |
4.8% |
| Suicide Attempt |
4.7% |
| Tremor |
4.7% |
| Weight Increased |
4.6% |
| Foetal Exposure During Pregnancy |
4.5% |
| Drug Withdrawal Syndrome |
4.1% |
| Suicidal Ideation |
3.4% |
| Heart Disease Congenital |
3.3% |
| Vomiting |
3.1% |
| Multiple Congenital Abnormalities |
2.9% |
| Talipes |
2.4% |
| Withdrawal Syndrome |
2.4% |
| Completed Suicide |
2.3% |
| Somnolence |
2.0% |
| Patent Ductus Arteriosus |
1.9% |
| Nausea |
1.6% |
| Pulmonary Artery Stenosis Congenital |
1.6% |
| Pulmonary Valve Stenosis |
1.5% |
|
| Secondary |
| Depression |
35.1% |
| Drug Use For Unknown Indication |
10.8% |
| Anxiety |
9.8% |
| Product Used For Unknown Indication |
9.7% |
| Insomnia |
5.2% |
| Panic Disorder |
4.4% |
| Social Phobia |
3.8% |
| Bipolar Disorder |
3.5% |
| Pain |
3.4% |
| Obsessive-compulsive Disorder |
2.2% |
| Hypertension |
2.2% |
| Major Depression |
1.7% |
| Herpes Zoster |
1.3% |
| Constipation |
1.2% |
| Headache |
1.1% |
| Fibromyalgia |
1.1% |
| Foetal Exposure During Pregnancy |
0.9% |
| Panic Attack |
0.9% |
| Migraine |
0.8% |
| Depressive Symptom |
0.8% |
|
| Ventricular Septal Defect |
10.7% |
| Weight Increased |
8.5% |
| Suicide Attempt |
7.4% |
| Somnolence |
6.8% |
| Vomiting |
6.6% |
| Drug Ineffective |
6.4% |
| Tremor |
6.2% |
| Weight Decreased |
5.9% |
| Suicidal Ideation |
5.8% |
| Drug Hypersensitivity |
5.3% |
| Drug Exposure During Pregnancy |
3.9% |
| Serotonin Syndrome |
3.9% |
| Withdrawal Syndrome |
3.5% |
| Completed Suicide |
3.2% |
| Parkinsonism |
3.0% |
| Drug Withdrawal Syndrome |
2.9% |
| Nausea |
2.9% |
| Mania |
2.6% |
| Tachycardia |
2.6% |
| Overdose |
2.3% |
|
| Concomitant |
| Depression |
17.2% |
| Product Used For Unknown Indication |
16.7% |
| Drug Use For Unknown Indication |
12.3% |
| Anxiety |
8.2% |
| Hypertension |
6.6% |
| Pain |
5.1% |
| Insomnia |
3.8% |
| Bipolar Disorder |
3.6% |
| Rheumatoid Arthritis |
2.8% |
| Sleep Disorder |
2.6% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Diabetes Mellitus |
2.3% |
| Prophylaxis |
2.3% |
| Osteoporosis |
2.2% |
| Smoking Cessation Therapy |
2.2% |
| Multiple Sclerosis |
2.1% |
| Multiple Myeloma |
2.0% |
| Asthma |
2.0% |
| Blood Cholesterol Increased |
1.8% |
| Hepatitis C |
1.8% |
|
| Weight Increased |
14.0% |
| Vomiting |
11.1% |
| Type 2 Diabetes Mellitus |
10.8% |
| Weight Decreased |
10.3% |
| Nausea |
4.9% |
| Suicidal Ideation |
4.2% |
| Tremor |
4.0% |
| Drug Ineffective |
3.9% |
| Urinary Tract Infection |
3.6% |
| Pain |
3.5% |
| Vision Blurred |
3.5% |
| Myocardial Infarction |
3.3% |
| White Blood Cell Count Decreased |
3.1% |
| Somnolence |
3.0% |
| Pneumonia |
3.0% |
| Suicide Attempt |
2.9% |
| Pulmonary Embolism |
2.9% |
| Rash |
2.8% |
| Pancreatitis |
2.7% |
| Death |
2.5% |
|
| Interacting |
| Depression |
19.7% |
| Smoking Cessation Therapy |
11.6% |
| Drug Use For Unknown Indication |
9.5% |
| Anxiety |
7.5% |
| Product Used For Unknown Indication |
7.5% |
| Pain |
6.1% |
| Diabetes Mellitus |
4.1% |
| Neuropathy Peripheral |
4.1% |
| Depressed Mood |
3.4% |
| Major Depression |
3.4% |
| Bipolar Disorder |
2.7% |
| Generalised Anxiety Disorder |
2.7% |
| Ill-defined Disorder |
2.7% |
| Insomnia |
2.7% |
| Schizoaffective Disorder |
2.7% |
| Back Pain |
2.0% |
| Irritability |
2.0% |
| Post-traumatic Stress Disorder |
2.0% |
| Schizophrenia |
2.0% |
| Agitation |
1.4% |
|
| Serotonin Syndrome |
14.3% |
| Sleep Disorder |
12.5% |
| Tooth Injury |
10.7% |
| Drug Interaction |
8.9% |
| Liver Disorder |
8.9% |
| Weight Increased |
7.1% |
| Vomiting |
5.4% |
| Metabolic Encephalopathy |
3.6% |
| Mood Swings |
3.6% |
| Suicidal Ideation |
3.6% |
| Upper Respiratory Tract Infection |
3.6% |
| Urinary Retention |
3.6% |
| Device Expulsion |
1.8% |
| Drug Hypersensitivity |
1.8% |
| Drug Ineffective |
1.8% |
| Euphoric Mood |
1.8% |
| Hallucination |
1.8% |
| Hypertension |
1.8% |
| International Normalised Ratio Increased |
1.8% |
| Multiple Drug Overdose |
1.8% |
|